Rothermel J D, Parker Botelho L H
Sandoz Research Institute, Sandoz Pharmaceuticals Corporation, East Hanover, NJ 07936.
Biochem J. 1988 May 1;251(3):757-62. doi: 10.1042/bj2510757.
The binding affinities of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate, Sp-cAMP[S] and Rp-cAMP[S], for the cyclic AMP- (cAMP-)binding sites on purified and reconstituted pig heart type II cAMP-dependent protein kinase holoenzyme were determined by measuring the ability of these compounds to displace [3H]cAMP from this enzyme. Sp-cAMP[S], a cAMP agonist, displaced 50% of the [3H]cAMP bound to the holoenzyme at a concentration 10-fold higher than that of cAMP; Rp-cAMP[S], a cAMP antagonist, required a 100-fold higher concentration relative to cAMP. Activation of the isolated holoenzyme, determined as phosphotransferase activity, was measured in the presence of the agonist and in the absence and in the presence of increasing concentrations of the antagonist. The results of fitting the activation data to sigmoid curves with a non-linear-regression program and to Hill plots by using a linear-regression program showed that Rp-cAMP[S] had no effect on Vmax, increased the EC50 values for agonist activation and had no effect on the co-operativity of activation (h). A Ki value of 11 microM was determined for Rp-cAMP[S] inhibition of cAMP-induced activation of purified type II cAMP-dependent protein kinase. Electrophoresis of the holoenzyme on polyacrylamide gels under non-denaturing conditions in the presence of saturating concentrations of the diastereoisomers resulted in 100% dissociation of the subunits with Sp-cAMP[S] and 0% dissociation with Rp-cAMP[S]. Sp-cAMP[S], the isomer with an axial exocyclic sulphur atom, binds to the holoenzyme, releases the catalytic subunit and activates the phosphotransferase activity. Rp-cAMP[S], the isomer with an equatorial exocyclic sulphur atom, binds to the holoenzyme but does not result in dissociation, and thus acts as a competitive inhibitor of phosphotransferase activity.
通过测量腺苷3',5' -(环)硫代磷酸酯的非对映异构体Sp - cAMP[S]和Rp - cAMP[S]从该酶上取代[³H]cAMP的能力,测定了它们与纯化和重组的猪心脏II型环磷酸腺苷(cAMP)依赖性蛋白激酶全酶上的cAMP结合位点的结合亲和力。cAMP激动剂Sp - cAMP[S]取代与全酶结合的[³H]cAMP的50%时的浓度比cAMP高10倍;cAMP拮抗剂Rp - cAMP[S]相对于cAMP所需浓度高100倍。在激动剂存在下以及在不存在拮抗剂和存在递增浓度拮抗剂的情况下,测定了以磷酸转移酶活性衡量的分离全酶的激活情况。用非线性回归程序将激活数据拟合到S形曲线以及用线性回归程序拟合到希尔图的结果表明,Rp - cAMP[S]对Vmax无影响,增加了激动剂激活的EC50值,并且对激活的协同性(h)无影响。测定Rp - cAMP[S]抑制纯化的II型cAMP依赖性蛋白激酶的cAMP诱导激活的Ki值为11μM。在非变性条件下,在饱和浓度的非对映异构体存在下,全酶在聚丙烯酰胺凝胶上进行电泳,结果显示Sp - cAMP[S]使亚基100%解离,而Rp - cAMP[S]使亚基0%解离。具有轴向环外硫原子的异构体Sp - cAMP[S]与全酶结合,释放催化亚基并激活磷酸转移酶活性。具有赤道环外硫原子的异构体Rp - cAMP[S]与全酶结合但不导致解离,因此作为磷酸转移酶活性的竞争性抑制剂起作用。